Research programme: small molecule therapeutics - Boehringer Ingelheim/Evotec AG

Drug Profile

Research programme: small molecule therapeutics - Boehringer Ingelheim/Evotec AG

Alternative Names: CB2 receptor agonists - Boehringer Ingelheim/Evotec; Enzyme modulators - Boehringer Ingelheim/Evotec; GPCR modulators - Boehringer Ingelheim/Evotec; Ion channel modulators - Boehringer Ingelheim/Evotec

Latest Information Update: 04 Nov 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Boehringer Ingelheim; Evotec AG
  • Developer Boehringer Ingelheim; Evotec AG; Evotec NeuroSciences
  • Class Benzylamines; Small molecules; Sulfonamides
  • Mechanism of Action G protein-coupled receptor modulators; Ion channel modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase Unknown Metabolic disorders
  • No development reported Cancer; Cardiovascular disorders; CNS disorders; Immunological disorders; Inflammation; Pain; Respiratory tract disorders

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for preclinical development in Cancer in Germany
  • 04 Nov 2017 No recent reports of development identified for preclinical development in Cardiovascular-disorders in Germany
  • 04 Nov 2017 No recent reports of development identified for preclinical development in Immunological-disorders in Germany
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top